We have increased the range of purified CYPs that we have available to include three new isoforms and two allelic variants.
We have been at the forefront of producing xenobiotic metabolising enzymes for almost 20 years, providing tools that give in vitro answers during your early stage drug development. Adding to our current range of purified recombinant human CYPs and related enzymes, we can now offer additional products: CYP2D6, CYP2B6, CYP1B1, CYP2C9*2 and CYP2C9*3 (all human) bringing the total number of isoforms available to 10. More details can be found here.
We are pleased to provide such a large range of purified human CYPs, with each enzyme prepared by the Institute of Bioorganic Chemistry within the National Academy of Sciences of Belarus.
All of our products can help mitigate late stage failure during drug development and our experienced team provides a cost effective and robust insight to support your efforts. This latest range of CYPs extends those capabilities further.
As each product is aliquotted to order, individual data sheets are currently unavailable but please contact us for more information and to discuss your specified volume and concentration.